[Fungi and polyps. Facts and myths].
Riechelmann
H
H
Univ.-HNO-Klinik Ulm. herbert.riechelmann@medizin.uni-ulm.de
D000281:Administration, Intranasal; D000391:Air Microbiology; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D004311:Double-Blind Method; D005658:Fungi / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D009181:Mycoses / Q000150:complications* / Q000276:immunology; D009298:Nasal Polyps / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012852:Sinusitis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology
D000935:Antifungal Agents; D000666:Amphotericin B